forgemax.FORGED. TESTED. PROVEN.
Clomiphene Citrate 50mg/tab 60 Tabletten by Sterling Knight Pharmaceuticals
Best Selling

Clomiphene Citrate 50mg/tab 60 Tabletten by Sterling Knight Pharmaceuticals

Sterling Knight Pharmaceuticals Clomiphene Citrate delivers 50 mg of pharmaceutical-grade clomiphene citrate per tablet across 60 tablets per pack — the compound-aware SERM of choice for structuring PCT after testosterone, Trenbolone, Nandrolone, or oral-only anabolic cycles, where each class of suppressive agent demands a distinct recovery approach. Because 19-nor compounds such as Trenbolone and Nandrolone suppress gonadotropins through both androgenic and progestogenic pathways, the higher-dose flexibility of a 50 mg tablet becomes particularly relevant when calibrating recovery intensity to compound class. Each batch is released only after per-tablet potency is confirmed via HPLC content-uniformity testing conducted against a certified reference standard — the lot-linked result travelling with the product record rather than inferred from formulation targets.

€38.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Supports compound-class-specific recovery — adaptable for testosterone, Trenbolone, Nandrolone, and oral-only cycles
  • 50 mg per tablet enables both 100 mg induction phases (19-nor protocols) and 25 mg taper doses via tablet splitting
  • 60-tablet pack accommodates standard 4-week and extended 5-to-6-week compound-specific recovery courses
  • HPLC content-uniformity confirmation per production lot — potency tied to a lot-specific instrument result, not a formulation estimate
  • LAL endotoxin screening applied across the oral solid-dosage line for pyrogenic safety verification
  • Consistent SERM mechanism regardless of which compound class induced suppression — LH, FSH, and testosterone axes all targeted

Key takeaways

  • Match your Clomiphene dose intensity to the specific compound class used.
  • Begin PCT earlier after orals than after long-ester 19-nor injectables.
  • Use two 50 mg tablets daily during 19-nor induction phases for adequate stimulus.
  • Confirm recovery completion with bloodwork — not calendar days alone.
  • Choose the 60-tablet pack to cover extended 19-nor protocols without reordering.

Clomiphene Citrate as a Compound-Specific PCT Tool

Clomiphene Citrate is a selective estrogen receptor modulator (SERM) that restores endogenous testosterone production by blocking hypothalamic estrogen receptors, thereby increasing pulsatile GnRH output and driving LH/FSH secretion — but the depth and character of that recovery task differs substantially depending on which anabolic compound or compound class was used. Sterling Knight Pharmaceuticals Clomiphene Citrate 50 mg/tab provides the dosing flexibility needed to calibrate PCT to the suppressive fingerprint of each specific agent: straight testosterone esters, 19-nor compounds (Trenbolone, Nandrolone/Deca), DHT derivatives, and oral-only protocols each impose different hormonal deficits that a single generic PCT template fails to address optimally.

Testosterone, 19-Nor, and Oral Cycles: Why PCT Intensity Differs

After a testosterone-only cycle, the HPG axis suppression is mediated primarily through androgen and estrogen negative-feedback loops; Clomiphene's SERM mechanism directly counters the estrogenic component, and recovery at 50 mg/day for two weeks followed by 25 mg/day for two weeks is well-supported for this scenario. Compared to testosterone, 19-nor compounds such as Nandrolone Decanoate and Trenbolone Acetate impose an additional progestogenic suppression vector — Nandrolone binds progesterone receptors with meaningful affinity, and Trenbolone's potent androgenic activity at the pituitary creates a more refractory suppression state. Both 19-nor agents therefore typically warrant longer or higher-dose Clomiphene induction phases, often 100 mg/day for the first week before stepping to 50 mg/day, reflecting the deeper gonadotropin deficit. Nandrolone Decanoate's extended half-life (approximately 6–7 days for the decanoate ester) also means PCT cannot begin until 3–4 weeks after the last injection — a washout requirement that does not apply to short-ester or oral-only scenarios.

Oral-Only Cycles and the 50 mg Dosing Advantage

For oral-only anabolic cycles, plasma clearance is rapid — most orals are eliminated within 24–48 hours — allowing PCT to begin within days of the final dose. Suppression depth in oral-only cycles is typically milder than equivalent injectable runs, and a standard 50 mg/day for two weeks, then 25 mg/day for two weeks protocol generally suffices; Sterling Knight's 50 mg/tab format supports both full-tablet and split-tablet precision across all compound-specific protocols. Clomiphene Citrate stimulates the pituitary to secrete LH and FSH, LH drives Leydig cell testosterone synthesis, and FSH restores spermatogenic function — all three axes benefit regardless of which compound class created the initial suppression. Each production lot of Sterling Knight Clomiphene Citrate 50 mg undergoes HPLC quantification of per-tablet API content before distribution clearance, with LAL endotoxin testing applied across the oral solid-dosage line to confirm pyrogenic safety.

Dosing Flexibility Across All Compound Classes

The 60-tablet pack accommodates the full range of compound-specific protocols: a standard 4-week testosterone-only PCT consumes 42–56 tablets at graduated doses, while a 5–6-week extended protocol for 19-nor recovery uses the remaining tablets without requiring a second purchase. Bloodwork measuring serum LH, FSH, and total testosterone at the end of the planned course provides the only objective confirmation that recovery targets have been met, regardless of the compound class used.

Usage

  1. Identify the specific compound(s) used and their ester half-lives — this determines both when to begin PCT and what dose intensity is appropriate for your compound class.
  2. For 19-nor compounds (Trenbolone, Nandrolone Decanoate), calculate the full washout window (minimum 3–4 weeks after last Decanoate injection) before opening your pack; for oral-only cycles, begin as early as 24–48 hours after the final tablet.
  3. Open your Sterling Knight blister pack and begin at the dose indicated for your compound class: 100 mg/day (2 tablets) for 19-nor induction, 50 mg/day (1 tablet) for testosterone or DHT-derivative protocols, or 50 mg/day for oral-only recovery.
  4. Take your daily tablet(s) with food to reduce the likelihood of gastrointestinal discomfort; for split 25 mg doses in the taper phase, divide the tablet and take the two halves at consistent intervals.
  5. Track any side effects compound-class-specifically — elevated estrogen rebound is a risk in testosterone cycles; mood disturbance may be more pronounced in 19-nor recoveries where progestogenic pathways are involved alongside SERM-mediated estrogenic shifts.
  6. At the conclusion of your protocol, obtain bloodwork measuring serum LH, FSH, and total testosterone to confirm the axis has recovered to reference range — the compound class used is the strongest predictor of whether a single 4-week course is sufficient or extension is warranted.

Warnings

Contraindications: Clomiphene Citrate is contraindicated in individuals with known hypersensitivity to clomiphene or any tablet excipient, pre-existing hepatic impairment, or a history of visual disturbances associated with prior SERM use. Patients with elevated baseline liver enzymes from prior hepatotoxic oral anabolic use should obtain liver function testing before initiating PCT.

Side Effects: Reported adverse effects include vasomotor symptoms (hot flashes), mood variability, transient visual disturbances such as floaters or blurring — the last of which requires immediate discontinuation — and occasional GI upset. 19-nor compound users may notice more pronounced mood effects during recovery due to lingering progestogenic activity interacting with the SERM-driven estrogenic shift.

Monitoring: Baseline bloodwork prior to PCT initiation is strongly recommended regardless of compound class used. End-of-protocol serum LH, FSH, and total testosterone measurements are the only objective method to determine whether the recovery course has achieved its endpoint — calendar-based PCT closure is not an adequate substitute for laboratory confirmation.

PCT: Clomiphene Citrate is intended as a therapeutic recovery agent; it does not function as an on-cycle aromatase inhibitor or estrogen control tool. Do not use concurrently with anabolic compounds. Compound-class selection — particularly the distinction between testosterone-only and 19-nor cycles — should drive protocol design decisions rather than generic fixed-duration templates.

Frequently asked questions

What PCT protocol should I follow after a Trenbolone cycle with Sterling Knight Clomiphene Citrate 50mg?
After Trenbolone — a potent 19-nor androgen — most practitioners recommend a higher induction dose of 100 mg/day (two 50 mg tablets) for the first week, stepping to 50 mg/day for weeks two and three, then 25 mg/day for week four. Trenbolone's progestogenic suppression at the pituitary makes the HPG recovery task harder than after a straight testosterone cycle, justifying the elevated opening dose. Begin PCT only after Trenbolone's ester-specific washout is complete.
Is PCT after a straight testosterone cycle less demanding than after Nandrolone Decanoate?
Yes — testosterone suppresses gonadotropins through androgen and estrogen feedback alone, whereas Nandrolone Decanoate adds a progestogenic suppression component via progesterone receptor binding. A testosterone-only PCT with Clomiphene at 50 mg/day for two weeks, then 25 mg/day for two weeks is generally sufficient. Nandrolone Decanoate cycles typically require a longer or front-loaded protocol, plus a delayed PCT start of 3–4 weeks after the final injection to allow for the decanoate ester's ~6–7-day half-life to fully clear.
What PCT approach works after an oral-only anabolic cycle when using Clomiphene Citrate?
Oral-only cycles permit an earlier PCT start — typically 24–48 hours after the final tablet — because most oral anabolics are cleared from plasma rapidly. Suppression from orals is usually less severe than from long-ester injectables, so a straightforward 50 mg/day for two weeks, then 25 mg/day for two weeks protocol with Sterling Knight's 50 mg tablets is typically sufficient. Splitting a single 50 mg tablet to achieve 25 mg doses in the taper phase is practical given the tablet format.
How does a 50mg tablet strength benefit compound-specific PCT compared to lower-dose formats?
A 50 mg per tablet format gives compound-specific PCT the flexibility to deliver 100 mg/day (two tablets) during a high-demand induction phase — relevant for 19-nor cycles — while also allowing single-tablet 50 mg/day dosing for testosterone-only recovery and half-tablet 25 mg/day dosing for the taper phase. Lower-strength tablets require more units per dose at the induction stage, whereas 50 mg covers the full dose range of current evidence-informed protocols with a single SKP pack of 60 tablets.
How does Sterling Knight Pharmaceuticals verify the potency of each Clomiphene Citrate 50mg tablet?
Sterling Knight conducts HPLC content-uniformity testing on each production lot, measuring per-tablet API against a certified reference standard before distribution clearance is granted. The resulting potency figure is tied to that specific lot number rather than extrapolated from batch averages, meaning the 50 mg declared on the label reflects an instrument-confirmed measurement. LAL endotoxin testing is additionally applied across the oral solid-dosage line to confirm pyrogenic safety across all released units. (2) angle_used

Manufacturer

Sterling Knight Pharmaceuticals' development rationale for its Clomiphene Citrate 50 mg/tab formulation reflects the brand's compound-coverage philosophy: across its catalogue, Sterling Knight tracks the distinct recovery requirements of different AAS classes — testosterone esters, 19-nor compounds, DHT derivatives, and oral agents — and sizes both the per-tablet dose and the pack count to serve the full range of compound-specific PCT applications within a single product SKU. The 50 mg per tablet specification is not a default; it is the precise API load that allows a single tablet to serve as a full induction-phase unit, a standard maintenance dose, or — when split — a taper-phase unit, depending on which compound's suppressive fingerprint drives the protocol. Sterling Knight's manufacturing process applies HPLC content-uniformity analysis at the finished-tablet stage against a certified reference standard, producing a per-lot potency record that is instrument-derived and lot-specific rather than extrapolated from raw material certificates — a distinction that matters when compound-specific protocols demand consistent delivery of either a full or a partial tablet dose across a multi-week recovery window.

Product details

BrandSterling Knight Pharmaceuticals
Active ingredientclomiphene citrate
Also known asClomiphene, Clomid, Clomiphen, Clomiphene Citratee, Sterling Knight Pharmaceuticals Clomiphene
Strength50 mg
FormTabletten
Pack size60 pieces
Item numberPCT-CLOM-STE-011

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Clomiphene Citrate 50mg/tab 24 Tablets by Anfarm HellasLab Tested

Clomiphene Citrate 50mg/tab 24 Tabletten by Anfarm Hellas

€12.00
Clomid 50mg/tab 50 Tablets by Beligas PharmaceuticalsHPLC Verified

Clomid 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

€36.00
CloTrex 50mg/tab 100 Tablets by Concentrex LabsPharma Grade

CloTrex 50mg/tab 100 Tabletten by Concentrex Labs

€45.00
Clomiphene Tablets 50mg/tab 50 Tablets by GenesisPurity Tested

Clomiphene Tablets 50mg/tab 50 Tabletten by Genesis

€24.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00